Banks Jerel A. 4
4 · Benitec Biopharma Inc. · Filed Dec 11, 2024
Insider Transaction Report
Form 4
Banks Jerel A.
DirectorChief Executive Officer
Transactions
- Award
Options (right to buy)
2024-12-09+2,310,000→ 2,310,000 totalExercise: $12.18Exp: 2034-12-09→ Common Stock (2,310,000 underlying)
Footnotes (1)
- [F1]The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025.